Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs. Potential mechanisms for this association include pharmacological effects, such as the ability of naltrexone to reduce alcohol cravings, as well as the impact of GLP-1 RAs on attenuating the rewarding effects of alcohol use.
Should Medicare, Medicaid Cover Anti-Obesity Drugs? Doctors Speak Out
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Does Medicare cover for anti-obesity medications? Find about the eligibility
The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the condition, including anti-obesity medications. However, man
Feds: Cover weight loss meds under Medicare, Medicaid
The Centers for Medicare and Medicaid’s proposed rule, which the Trump administration would need to finalize before it would take effect, is expected to cost $25 billion for Medicare combined with $11 billion in federal spending and $3.8 billion in state spending for Medicaid coverage throughout the next decade.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Medicare proposes covering weight-loss drugs, teeing up clash with RFK Jr.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden administration said.
Biden administration adds weight-loss drugs to Medicare
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and Mounjaro — accessibility to these drugs is limited. The average prescription costs $1,
Biden's plan to cover anti-obesity drugs could cost $140 billion
President Joe Biden's plan to authorize Medicare and Medicaid cover anti-obesity medications starting in 2026 would $140 billion over the next decade.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity medications. But it's not clear if the proposed change will go into effect.
The future of Biden's plan for Medicaid to cover obesity drugs
Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.
Iowa Public Radio36m
Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
Why your copay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
justthenews14h
Changes proposed to Medicare Advantage, Part D programs
The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...
How anti-obesity drugs are linked to food waste: 1 in 4 users report an increase in discarding food
Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, ...
Losing Weight With Ozempic Might Also Lighten Your Bar Tab, Study Finds
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
Acsh.org2d
My Ozempic Journey: Shedding Pounds – and Alcohol
Who knew weight loss and wine could be frenemies? My journey with Ozempic started as a bid to shed pounds, but it ...